Updates

CSRxP Encourages HELP Committee To Take Up Bipartisan FAIR Drug Pricing Act

Jun 17, 2019

Greater List Price Transparency Will Help Crack Down on Big Pharma’s Read More

CSRxP: Big Pharma Desperate to Distract from Egregious Pricing Practices

Jun 12, 2019

Drug Makers Intensify Blame Game While Seeking to Avoid Accountability Read More

CSRxP Survey: Vast Majority of Americans Want Washington to Focus on Solutions That Crack Down on Big Pharma

Jun 6, 2019

Poll Finds U.S. Adults Blame Drug Makers for Rising Prices, Oppose Read More

CSRxP Urges HELP Committee to Strengthen Drug Pricing Package with Measures to Boost Competition and Transparency

Jun 5, 2019

Bipartisan CREATES, FAIR Drug Pricing and REMEDY Acts Will Deliver Relief for Read More

CSRxP: Senators Should Hold Big Pharma Accountable for Patent Abuse, Question Proposal to Loosen Rules

Jun 3, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Applauds National Governors Association’s Commitment to Lowering Drug Prices

May 31, 2019

NGA’s “2019 Principles for Federal Action to Address Health Care Costs” Read More

CSRxP Appreciates HELP Leaders’ Bipartisan Commitment to Lowering Drug Prices

May 23, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released Read More

THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices

May 22, 2019

Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on Read More

Lawmakers Keeping Up Bipartisan Momentum On Drug Pricing

May 21, 2019

House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 18, 2019

Part IV:  Big Pharma’s Tax Conundrum The average American spends $1 Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 17, 2019

Part III:  As Prices Rise, So Too Does Ad Spending The average American Read More

CSRxP: House Passage of Bipartisan CREATES Act a Pivotal Moment for Patients

May 16, 2019

Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices Read More